Guaraldi, G;
Meschiari, M;
Milic, J;
Cozzi-Lepri, A;
Mussini, C;
(2020)
Tocilizumab for severe COVID-19 pneumonia – Authors' reply.
The Lancet Rheumatology
10.1016/S2665-9913(20)30285-X.
(In press).
Preview |
Text
Tocilizumab for severe COVID-19 pneumonia - Authors reply.pdf - Published Version Download (106kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Tocilizumab for severe COVID-19 pneumonia – Authors' reply |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/S2665-9913(20)30285-X |
| Publisher version: | https://doi.org/10.1016/S2665-9913(20)30285-X |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10109339 |
Downloads since deposit
35Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
